(Alliance News) - Tristel PLC on Monday looked "positively" to the future, highlighting opportunities in the US after reporting a strong first half. Read More
(Alliance News) - Tristel PLC on Tuesday said its Tristel ULT device has been approved by Health Canada as a high-level disinfectant for use on endocavity ultrasound probes and skin surface transducers. Read More
(Alliance News) - Tristel PLC on Tuesday celebrated what it expects to be a "record" first half, after seeing revenue growth thanks to a strong performance across all of its markets. Read More
(Alliance News) - Tristel PLC on Monday posted a surge in annual profit and said its outlook was the strongest it has been in its 30-year history. Read More
(Alliance News) - Tristel PLC on Monday said it submitted its application to Health Canada to approve Tristel ULT as a class 2 medical device for endocavity ultrasound probes and skin surface transducers. Read More
Tristel PLC - Cambridgeshire-based maker of infection prevention products - Chief Executive Officer Paul Swinney sells 100,000 shares at 350 pence each, worth GBP350,000, in London on Thursday. Swinney is now interested in 312,350 shares, a 0.66% stake. Read More
(Alliance News) - Stock prices in London were higher at midday on Monday as markets looked to further positive news for the UK's service sector. Read More
(Alliance News) - Tristel PLC on Monday said it was granted approval from the US Food & Drug Administration for its ultrasound disinfectant for immediate sale. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Tristel PLC on Monday reported that it swung to an interim profit in the six months to December 31, as its disinfectant foam De Novo could be approved by the US Food & Drug Administration. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
